| Pharmaceutical active ingredients: |
| Clonidine |
| Available forms, composition and doses of Catapressan: |
| Injectable; Injection; Clonidine Hydrochloride 0.15 mg / mlTablets; Oral; Clonidine Hydrochloride 0.15 mg |
| Catapressan medical category: |
| Human:AntihypertensivesCentral alpha-agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AC01 - Clonidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |
| Related documents and information about Catapressan: |
| Catapres prescribing information (PDF)Catapres-TTS prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Catapin | Clonidine Hydrochloride | Oboi Laboratories; Phil Pharmawealth |
| Cataplasme Sinapise Defresne | Linseed Flour; Mustard Flour de-oiled | Chefaro-Ardeval Laboratoires |
| Catapres | Clonidine Hydrochloride | Boehringer Ingelheim; German Remedies; Metro Drug Distribution; Zydus Cadila |
| Catapres Diu | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim; German Remedies; Zydus Cadila |
| Catapresan | Clonidine | Boehringer Ingelheim |
| Catapres-TTS | Clonidine | Boehringer Ingelheim |
| Catarase | Chymotrypsin | Novartis; Iolab Pharmaceuticals |
| Cataren | Diclofenac Potassium | Instituto Nacional de Quimioterapia |
| Catarest | Calcium Chloride; Potassium Iodide; Sodium Chloride | Centaur Laboratories |
| Cataridol | Calcium Chloride; Magnesium Chloride; Sodium Chloride | Novartis |